U.S. Insurance Stock News

Compass stock snapshot after recent price moves Compass (COMP) has drawn fresh attention after recent share price swings, with a 3.6% gain over the past day contrasting with weaker performance over the past week and month. See our latest analysis for Compass. That 3.6% 1 day share price return comes after a 18.7% 30 day share price decline, while the 3 year total shareholder return of around 7x suggests the longer term story has been much stronger than recent trading. If Compass’s swings have...

Cullen/Frost Bankers (NYSE:CFR) highlights a robust dividend record, with a pattern of regular increases that outpaces many peers. The company presents this dividend profile as evidence of sustained financial strength and a positive outlook for future earnings. The bank indicates potential for further dividend growth, reinforcing its appeal for income focused shareholders. Cullen/Frost Bankers, a Texas based regional bank, is putting its dividend front and center at a time when many...

PROG Holdings (PRG) has just posted its FY 2025 third quarter results with revenue of $595.1 million and basic EPS of $0.83, set against a trailing twelve month revenue base of about $2.5 billion and EPS of $4.04. Over recent quarters the company has seen revenue move between $592.2 million and $684.1 million, while quarterly EPS has ranged from $0.79 to $1.99. This gives investors a clearer view of how earnings and sales have tracked into the current print. With a trailing net margin of 6.5%...

Recent share performance context Deckers Outdoor (DECK) has attracted fresh attention after a strong run in its shares, with the stock up about 18% over the past month and roughly 46% in the past 3 months. See our latest analysis for Deckers Outdoor. That recent momentum builds on a 30 day share price return of 18.1% and a 90 day share price return of 45.9%. However, the 1 year total shareholder return is a 22.1% decline and the 5 year total shareholder return is 115.2%. If strong moves in...

ColdQuanta (INFQ) remains in focus for investors after recent trading left the share price at US$14.71, with short term moves including a 5.6% one day decline and mixed month and past 3 months returns. See our latest analysis for ColdQuanta. Those recent moves sit within a wider pattern where the 90 day share price return of 11.2% contrasts with a 14.7% 1 month share price decline. This suggests that momentum has cooled after an earlier upswing. If ColdQuanta’s quantum focus has your...

Hycroft Mining Holding (NasdaqCM:HYMC) reported a 55% increase in gold and silver mineral resources. The company identified new high grade silver systems with potential for underground mining. Hycroft also announced upcoming changes to its board, including the departure of a key member for health reasons. Hycroft Mining focuses on gold and silver production and development, so a 55% rise in mineral resources directly affects how investors think about the company’s asset base. The discovery...

Avantor (AVTR) has drawn fresh attention after recent price moves left the stock with a negative return over the past year and a value score of 5, prompting investors to reassess its risk reward profile. See our latest analysis for Avantor. Despite a 2.43% 1 day share price gain, Avantor’s 30 day share price return of a 23.77% decline and 1 year total shareholder return of a 47.57% loss point to fading momentum and a tougher recent backdrop for investors. If Avantor’s recent swings have you...

Robotti Value Investors recently highlighted Tidewater (TDW) in its fourth quarter 2025 letter, pointing to the company’s stronger balance sheet, consolidated fleet, and tighter offshore energy supply-demand conditions supporting renewed pricing power. See our latest analysis for Tidewater. Tidewater’s recent investor attention from Robotti comes alongside strong price momentum, with a 24.35% 1 month share price return and a 36.78% year to date share price return. The 5 year total shareholder...

If you are wondering whether Merck's share price still offers value at current levels, this article walks through what the numbers are really saying about the stock. Merck last closed at US$121.66, with returns of 2.0% over 7 days, 11.8% over 30 days, 14.3% year to date, 47.5% over 1 year, 22.1% over 3 years and 100.5% over 5 years, which naturally raises questions about what is already priced in. Recent news coverage around Merck has focused heavily on its role in the pharmaceuticals and...

In recent weeks, analysts have issued mixed updates on Asana, citing weak billings growth, customer churn tied to commoditized work management software, and the complexity of large enterprise implementations, alongside commentary on AI initiatives and management changes. This combination of caution around customer retention and optimism about AI-driven products and potential operational improvements has sharpened investor focus on how Asana can reposition its platform and go-to-market...

If you are wondering whether Community Financial System is priced fairly at around US$63.92, taking a closer look at its valuation metrics can help you see what the market might be factoring in. The stock has had mixed short term moves, with a 3.6% decline over the last 7 days, a 3.5% return over the last 30 days, and a 10.0% return year to date, while the 1 year return sits at 1.3% and the 3 year return at 18.8%. Recent coverage of Community Financial System has focused on its position...

Lazard: recent performance and context Lazard (LAZ) has drawn attention after recent share moves, with the stock up about 12% over the past 3 months but roughly flat over the past year, prompting closer scrutiny from income and value focused investors. See our latest analysis for Lazard. Recent moves around Lazard have been mixed, with a 12.4% 90 day share price return and a 4.5% year to date share price return. The 1 year total shareholder return sits close to flat, suggesting interest is...

Fluor Corporation recently reported fourth-quarter 2025 results showing revenue of US$4.18 billion, a net loss of US$1.57 billion, and full-year 2025 sales of US$15.50 billion alongside continued share repurchases and NuScale stake monetization. At the same time, Fluor has been chosen for large energy and mining assignments, including Centrus Energy’s multi-billion-dollar uranium enrichment expansion and the Donlin Gold bankable feasibility study, while reaffirming a grow-and-execute focus...

Roper Technologies (ROP) is back in focus after its Q4 2025 report, where revenue growth and an adjusted earnings beat were paired with a decline in net earnings and more cautious guidance. See our latest analysis for Roper Technologies. The Q4 update landed against a weak backdrop for the stock, with a 30 day share price return of a 21.3% decline and a year to date share price return of a 24.6% decline, while the 1 year total shareholder return is down 42.9%. This points to fading momentum...

Caterpillar has agreed to acquire RPMGlobal Holdings Limited, adding mining software and data analytics capabilities to its existing mining solutions. Caterpillar Venture Capital is participating in ElevenEs’ Series B funding round to support development of a lithium iron phosphate battery giga-factory. These moves expand Caterpillar’s reach in both mining technology and battery focused energy infrastructure. For investors watching NYSE:CAT, these developments come as the stock trades...

In February 2026, Otter Tail Corporation reported its fourth quarter and full-year 2025 results, showing higher quarterly sales of US$149.71 million but lower net income of US$51.77 million, alongside full-year diluted EPS from continuing operations of US$6.55 and new 2026 diluted EPS guidance of US$5.22 to US$5.62. The company also lifted its dividend for the 88th consecutive year and outlined a US$1.90 billion-plus capital plan centered on renewables, transmission, and battery storage, to...

In early February 2026, Globe Life Inc. raised its full-year 2026 earnings guidance, projecting net operating income between $14.95 and $15.65 per diluted share, signaling management’s updated expectations for the business. This guidance increase offers investors a clearer benchmark for assessing how Globe Life’s capital deployment, underwriting discipline, and distribution initiatives are translating into expected profitability. We’ll now examine how Globe Life’s higher 2026 earnings...

Vertex Pharmaceuticals (NasdaqGS:VRTX) and CRISPR Therapeutics are ramping up patient treatments with Casgevy, a gene-editing therapy. Casgevy is approved for sickle cell disease and beta thalassemia, marking a key step in bringing gene-editing into routine clinical use. The current focus is on moving from approval to broader real-world deployment across eligible patient populations. For you as an investor, Casgevy sits at the intersection of Vertex's established role in serious diseases...

Recent analysis shows that over the past two years Greenbrier Companies has faced declining unit sales, softer demand, a 14% gross margin that trails peers, and free cash flow shortfalls, all of which have prompted fresh scrutiny of its operating model. A key concern is that weaker margins and cash generation may limit Greenbrier’s ability to fund marketing, innovation, and other investments needed to strengthen its competitive position. We’ll now examine how concerns about declining unit...

If you are wondering whether Liberty Latin America is priced attractively right now, you are not alone. The stock's recent moves have raised fresh questions about what a fair value really looks like. The share price sits at US$7.73, with returns of 6.5% year to date, 7.2% over 1 year, 3.2% over 30 days and a 6.0% decline over the last week, alongside longer term declines of 12.5% over 3 years and 31.2% over 5 years. These mixed returns come as investors continue to reassess Liberty Latin...

On February 17, 2026, Global Business Travel Group, Inc. reaffirmed its full-year 2026 revenue guidance of 19%–21% growth to US$3.24–US$3.30 billion and expanded its share repurchase authorization to US$600 million after completing US$100 million of buybacks covering 2.57% of its shares. The combination of higher buyback capacity and continued revenue growth guidance highlights management’s confidence in cash generation, post‑CWT integration progress, and the role of AI-enabled offerings in...

TG Therapeutics (TGTX) is back in focus after publishing five year data from the open label extension of its Phase 3 ULTIMATE I and II BRIUMVI trials in relapsing multiple sclerosis, highlighting durable efficacy and safety. See our latest analysis for TG Therapeutics. The latest BRIUMVI data arrive as TG Therapeutics trades at US$29.23, with a 7 day share price return of 1.42% but a 30 day share price return decline of 4.38%. A 3 year total shareholder return of 72.96% contrasts with a 5...

Integer Holdings Corporation has released its fourth-quarter and full-year 2025 results, reporting higher quarterly sales of US$472.06 million and net income of US$48.61 million, alongside full-year sales of US$1.85 billion but lower annual net income of US$102.81 million compared with the prior year. The company also issued 2026 guidance calling for US$1.83–1.88 billion in sales and diluted EPS of US$3.53–4.01, framing investor expectations amid earlier guidance concerns and ongoing...

Occidental Petroleum (NYSE:OXY) has launched a series of cash tender offers for certain senior notes and debentures. The company is using proceeds from the completed US$9.7b OxyChem divestiture to reduce debt. Alongside the liability actions, Occidental has announced an 8% quarterly dividend increase. Occidental Petroleum, a large upstream and integrated energy company, is in a new phase of balance sheet repair following its Anadarko acquisition period. The combination of debt tenders and a...